Novocure is a global oncology company working to extend survival in some of the most aggressive forms of cancer through the development of its innovative therapy, Tumor Treating Fields (TTFields). Novocure has ongoing clinical trials investigating TTFields targeting specific lung, pancreatic, ovarian, hepatic, and gastric cancers, brain metastasis, and glioblastoma.

The information provided here is intended as an educational resource for healthcare professionals and researchers practicing in the United States. It may include information about products or uses that have not been approved by the U.S. Food and Drug Administration. If you are not a U.S. healthcare professional or researcher, please visit Novocure.com.